Altimmune

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.

About ALT

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH.

CEO

Vipin K. Garg

CEOVipin K. Garg

Employees

Employees59

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1997

Founded1997

Employees

Employees59

ALT Key Statistics

Market cap

509.74M

Market cap509.74M

Price-Earnings ratio

-4.37

Price-Earnings ratio-4.37

Dividend yield

—

Dividend yield—

Average volume

3.08M

Average volume3.08M

High today

$7.45

High today$7.45

Low today

$6.81

Low today$6.81

Open price

$7.18

Open price$7.18

Volume

2.68M

Volume2.68M

52 Week high

$14.84

52 Week high$14.84

52 Week low

$2.09

52 Week low$2.09

ALT News

Yahoo Finance 20h

Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 - Yahoo Finance

Altimmune, Inc GAITHERSBURG, Md., May 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced t...

Yahoo Finance 2d

Altimmune to Participate at Two Upcoming Conferences - Yahoo Finance

Altimmune, Inc GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced t...

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell